Do you need help with your daily insulin injections?
Multiple daily injection (MDI) therapy can be complicated. Smart MDI may help.
For people living with type 1 or type 2 diabetes, we have tools to help you stay ahead.
For people who manage their diabetes with insulin injections, Smart MDI helps relieve the physical and mental effort required, by using an ecosystem of smart-enabled technology devices, to help make your life a bit easier.
Smart MDI includes a continuous glucose monitor (CGM), an injection port, and smart pen products.
If you aren’t ready for or interested in a pump, Smart MDI offers some of the advantages of insulin pumps while still offering the freedom of daily injections. The Smart MDI family works together to make staying ahead of diabetes easier. And with the ability to share data with your healthcare provider, it could make coming up with the best treatment plan easier too!
Get ahead of your highs
The only continuous glucose monitor (CGM) that can predict a high or low up to an hour in advance.*
Learn how foods & activities affect your sugars
The right dose at the right time
Bluetooth® enabled smart pen that does the math and logs doses for you.
Get personalized dosing recommendations
It takes the shots for you
Deliver your insulin injections without having to puncture your skin for each shot.
93% reduction in needle pokes**
References
* Alerts must be set to receive predictive alerts
** Based on 150 injections per month versus 10 insertions per month
The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by Medtronic is under license.
Important Safety Information: Guardian™ Connect CGM System
The Guardian™ Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices, and is not recommended for people who are unwilling or unable to perform a minimum of two meter blood glucose tests per day, or for people who are unable or unwilling to maintain contact with their healthcare professional. The system requires a functioning mobile electronic device with correct settings. If the mobile device is not set up or used correctly, you may not receive sensor glucose information or alerts. For complete details of the system and its components, including warnings, contraindications, and precautions, please consult the user guides and important safety information.
Safety Information: i-Port Advance™ injection port
i-Port Advance™ injection port is indicated for patients who administer or receive multiple daily subcutaneous injections of physician prescribed medications, including insulin. The device may remain in place for up to 72 hours to accommodate multiple injections without the discomfort of additional needle sticks. i-Port Advance™ injection port may be used on a wide range of patients, including adults and children. For more, please see important safety information.
Important Safety Information: InPen™
The InPen™ is a home- use reusable pen injector for single- patient use by people with diabetes under the supervision of an adult caregiver, or by a patient age 7 and older for the self- injection of a desired dose of insulin and for calculating an insulin dose or carbohydrate intake based on user entered data. A healthcare professional must assist in dosage programming of the device prior to use, based on various patient- specific criteria and targets. The InPen™ requires a prescription. For additional product and safety information, please consult the Instructions for Use and bit.ly/InPenRisks.com.